-
StockWatch: PacBio Faces Uphill Climb as Q1 Revenue Falls Short
19 Apr 2024 03:45 GMT
… PacBio also fell short in revenue from Revio consumables, generating … $16 million in preliminary revenue from consumables reported by … group compared with placebo.
Marinus Pharmaceuticals (MRNS) shares plunged 83% … the FDA in the first half of 2025 with a …
-
Q1 2024 Revenue and Business Update
17 Apr 2024 07:05 GMT
… on track for H1 2024
The Biologics License … Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Investor Relations … ’s expenses, future revenues and capital requirements; … ©2024 Telix Pharmaceuticals Limited. The Telix Pharmaceuticals®, Illuccix®, Zircaix …
-
Melodiol unaudited revenue up 79% in Q1 FY24
17 Apr 2024 03:19 GMT
… potential upside to round out H1 CY24.
Health House … Chemovar, Endoca, Quantum.
MedTEC Pharma has also chosen HHA as … delivered $647,000 in revenue during the quarter, reflecting … diligently towards growing our substantial revenue base.”
This article was …
-
Why Did Epilepsy/Seizure Focused-Marinus Pharmaceuticals Stock Hit 52-Week Low On Monday?
15 Apr 2024 14:42 GMT
Monday, Marinus Pharmaceuticals Inc MRNS announced that … to the FDA in the first half of 2025 with a … intended to provide improved pharmacodynamic and pharmacokinetic profiles that improve safety … in preliminary unaudited net product revenue of between $7.4 …
-
Germany Warehousing and Cold Storage Market Thriving at 5.95% CAGR - Poised for $5 Billion Revenue Surge by 2030
15 Apr 2024 12:39 GMT
… space uptake in the first half of 2023.
■ … , including food and pharmaceuticals, with specialized storage … Cities
Warehousing Sector Revenue and Forecast
► … • Retail
• E-commerce
• Pharmaceuticals
► Competitive Landscape
• Mergers…
-
Marinus Pharma Says RAISE Trial Did Not Meet The Early Stopping Criteria; Stock Dips In Pre-market
15 Apr 2024 14:20 GMT
… the interim analysis.
The pharma company focused on the … Drug Administration in the first half of 2025 with a … intended to provide improved pharmacodynamic and pharmacokinetic profiles that could … resulting in preliminary net product revenue of between $7.4 …
-
Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results
15 Apr 2024 11:11 GMT
… Administration in the first half of 2025 with … to provide improved pharmacodynamic and pharmacokinetic profiles that … may provide improved pharmacodynamic and pharmacokinetic profiles that could … regarding expenses, future revenue, capital requirements, and …
-
FTSE 100 Live: Blue-chips up as easyJet and British Airways take off
18 Apr 2024 11:50 GMT
Blue-chip index up 18 points at 7,866
Rentokil dips following results
easyJet bolstered following trading update
12.44pm: Co-op Bank on brink of merger with Coventry Building Society
The Co-operative Bank is set to announce its takeover by Coventry …
-
FTSE 100 Live: Index higher; easyJet and British Airways owner gain
18 Apr 2024 11:06 GMT
Blue-chip index up 13 points at 7,861
Rentokil dips following results
easyJet bolstered following trading update
11.44am: British Airways boosted by transatlantic demand outlook
Shares in British Airways owner International Consolidated Airlines Group SA ( …
-
Sartorius Aktiengesellschaft (SARTF) Q1 2024 Earnings Call Transcript
18 Apr 2024 18:56 GMT
… rather expecting a moderate first half of the year. … profitable growth with a moderate first half of the year. Consolidated group sales revenue … also larger research-oriented pharmaceutical companies, et cetera. … always said, indeed, first half of the year, we …